Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study
暂无分享,去创建一个
I. Ranasinghe | G. Gamble | F. Turnbull | R. Tavella | D. Chew | D. Brieger | T. Briffa | J. Redfern | J. Lefkovits | J. French | C. Astley | C. Ellis | K. Hyun | B. Aliprandi-Costa | C. Hammett | B. Carr | K. Lintern | T. Howell | H. Parker | S. Bloomer | Tegwen E. Howell
[1] D. Chew,et al. Measuring performance and outcomes of acute coronary syndromes management in Australia , 2012, The Medical journal of Australia.
[2] I. Ranasinghe,et al. Comparative Effectiveness of Population Interventions to Improve Access to Reperfusion for ST-Segment–Elevation Myocardial Infarction in Australia , 2012, Circulation. Cardiovascular quality and outcomes.
[3] S. Gallagher,et al. Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms , 2012, Heart.
[4] S. Stewart,et al. Application of Geographic Modeling Techniques to Quantify Spatial Access to Health Services Before and After an Acute Cardiac Event: The Cardiac Accessibility and Remoteness Index for Australia (ARIA) Project , 2012, Circulation.
[5] S. Allen,et al. From the Australian Commission on Safety and Quality in Health Care , 2011, The Medical journal of Australia.
[6] K. Mahaffey,et al. Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) , 2012 .
[7] P. Davidson,et al. Lost in Translation: Health Resource Variability in the Achievement of Optimal Performance and Clinical Outcome , 2011, Circulation. Cardiovascular quality and outcomes.
[8] H. White,et al. 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. , 2011, Heart, lung & circulation.
[9] R. Califf,et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[10] Judith S. Hochman,et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[11] I. Crozier,et al. High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain , 2011, Annals of clinical biochemistry.
[12] Eric Boerwinkle,et al. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.
[13] H. Katus,et al. Troponin elevation in coronary vs. non-coronary disease. , 2011, European heart journal.
[14] H. White,et al. ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients. , 2010, The New Zealand medical journal.
[15] H. White,et al. Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. , 2010, The New Zealand medical journal.
[16] Tobias Reichlin,et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.
[17] H. Bueno,et al. Patient Registries of Acute Coronary Syndrome: Assessing or Biasing the Clinical Real World Data? , 2009, Circulation. Cardiovascular quality and outcomes.
[18] D. Chew,et al. Acute coronary syndromes: consensus recommendations for translating knowledge into action , 2009, The Medical journal of Australia.
[19] J. Amerena,et al. Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes , 2009, Heart.
[20] I. Ranasinghe,et al. Management and Outcomes of Patients with Acute Coronary Syndromes in Australia and New Zealand 2000–2007 , 2009 .
[21] J. Amerena,et al. Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry , 2009, The Medical journal of Australia.
[22] I. Scott,et al. Discordance between level of risk and intensity of evidence‐based treatment in patients with acute coronary syndromes , 2007, The Medical journal of Australia.
[23] A. Yan,et al. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. , 2007, Archives of internal medicine.
[24] F. Van de Werf,et al. External validity of clinical trials in acute myocardial infarction. , 2007, Archives of internal medicine.
[25] K. Eagle,et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.
[26] A. Tonkin,et al. Guidelines for the management of acute coronary syndromes 2006 , 2006, The Medical journal of Australia.
[27] H. White,et al. Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. , 2004, The New Zealand medical journal.
[28] A G Babiker,et al. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.